TOP 10 – BIO-PHARMACEUTICAL COMPANIES

R & D PIPELINE SIZE: 160 EMPLOYEES: 57,000 CIO: LINDA RAY

Chicago-based Abbvie, formerly part of Abbott Laboratories until the pair separated in 2013, has a pipeline led commercially by immunology drugs Skyrizi and Rinvoq. Its pipeline spans immunology, oncology and neuroscience, bolstered by acquisitions of Cerevel in neuroscience and ImmunoGen in oncology, plus aesthetics in the form of Botox and eye care franchises. AbbVie’ s R & D strategy is centred on replacing and expanding established medicines while developing new therapies with blockbuster potential.

How AbbVie uses technology to accelerate drug development for patients

CREDIT: ABBVIE healthcare-digital. com 35